skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: EMR.us (Emerson Electric, NYSE)
1. Do you see growth in revenue, and ROE ?
2. Is EMR a dividend grower?
3. After the pullbacks after Oct 2018 , is EMR good value?
4. Most financial sites leave PEG as blank. Yahoo Finance (not always reliable) is the only one I saw that reported PEG (at 1.45).
5. I hold EMR in a registered retirement account; it is in a conservative retirement fund. I take massive risks on my other accounts, but on the registered account I am interested in growth, ROE not too far from 20 ; PEG not TOO far from 1.0 --- and feel 2 or 3 the above would be adequate reasons to continue holding EXCEPT IF YOU HAVE BETTER IDEAS.
6. RBC downgraded EMR today; yesterday Credit Swisse upgraded. Analyst ratings are a not deciding factor, but I do look at them notwithstanding the migraines they cause.
7. Is EMR worth keeping or could one do better elsewhere?


Read Answer Asked by Adam on January 10, 2019
Q: Hi there,
Can you please provide your top two picks for someone wanting US exposure in the following areas? Ideally something either oversold or poised to capitalize on circumstances in coming years.

Financial
General healthcare
Bio/pharma
Consumer discretionary
Technology (large cap)
Technology (mid cap)
Miscellaneous (whatever you want)

Goal is growth blended with safety over the next 5+ years
Take whatever credits you need please to justify a thorough answer with a brief comment on each suggestion.
Read Answer Asked by Tim on January 09, 2019
Q: How likely is Mindbody going to receive a sweetened offer from Vista Equity Partners based on your experience?

Is the deal at risk here?

The cash offer represented a 68% premium to the prior trading day’s closing price but the SP was depressed due to recent reduced guidance combined with the fall's downturn. Shares have been trading at or near the purchase price of $36.50.
Read Answer Asked by Dominic on January 08, 2019
Q: Hi fellows,
In the US consumer cyclical sector, would crox be a good buy now in view of the coming spring/summer and is it very sensitive to the Asian markets ? What would be your favorites in the consumer cyclical sector, Canada and USA, for the coming months ?

Have a good year in all regards,

JD
Read Answer Asked by Jacques on January 08, 2019
Q: I've noticed that despite the tech meltdown recently, some have held up quite well such as RPD (Rapid 7). I found this a bit surprising given that the company was smaller than others such as NVDA.

Is the relative strength a positive sign? Are there other notable tech companies with positive relative strength vs peers? Thanks!
Read Answer Asked by Mike on January 08, 2019
Q: I am a 75 year old RIF investor and generally invest conservatively in dividend paying companies, but I do like to allot a portion of the investment to something that might fly.

I have previously owned GC and TSGI, but sold both at a loss and bought LVS, which at least pays a dividend. It too, has been a loser, so I would like to know whether There is more chance of recovery with GC or TSGI than LVS, or whether I should just stay the course.

What are your thoughts?
Read Answer Asked by John on January 08, 2019
Q: Do you know when is Apple next earnings call ? I would like to see some analyst challenge CEO Cook about outrageous pricing that pushes them out of the market. Did he mislead the investor on November first when he said that “business in China was very strong?” If things goes really bad is it possible that the board could remove Cook as CEO before the end of 2019 ?
Read Answer Asked by Martin on January 08, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!